FINWIRES · TerminalLIVE
FINWIRES

午盘涨幅最大的股票

By

-- KalVista Pharmaceuticals (KALV) 和 Chiesi Group 周三宣布，双方已达成最终协议，Chiesi 将以每股 27 美元的现金收购 KalVista，总交易额约为 19 亿美元。双方表示，该交易预计将于第三季度完成。 受此消息提振，KalVista 股价飙升 39%，盘中交易量从日均约 98.4 万股增至超过 4820 万股。 Silicon Motion Technology (SIMO) 周二晚间公布的第一季度非 GAAP 盈利和销售额均同比增长，超出市场预期。 受此消息提振，Silicon Motion Technology (SIMO) 股价飙升 31%，盘中交易量从日均约 62.3 万股跃升至超过 266 万股。 Bloom Energy (BE) 周二晚间公布的第一季度调整后每股收益为 0.44 美元，高于去年同期的 0.03 美元。FactSet 调查的分析师此前预期为 0.12 美元。该公司营收也轻松超出分析师预期。 受此消息提振，该公司股价飙升22%，盘中交易量从日均约1080万股飙升至超过1380万股。

Price: $26.71, Change: $+7.47, Percent Change: +38.80%

Related Articles

Commodities

US Biofuels Update: Soybean Oil Futures Reach All-Time Highs, Pushing Soybeans Higher

Biofuels feedstock futures closed higher on Wednesday, with soybean oil reaching contract highs, while soybean prices followed.The Chicago Board of Trade July soybean futures contract closed 0.65% higher on Wednesday at $11.97 per bushel, while the CBOT July soybean oil futures contract settled 2.21% higher at 74.12 cents per pound.On Tuesday, the June ethanol futures contract on the Nymex ended 0.87% lower at $1.99 per gallon.US President Donald Trump reportedly plans to keep the US blockade in place, and as a result, crude futures jumped on Wednesday for the seventh time in the past eight sessions.Rhett Montgomery, DTN analyst, said that fresh fundamental news was slim on Wednesday."Soybeans are likely getting a boost from another contract high in soybean oil futures. Crush premiums continue to expand and are closing in on all-time highs set in October of 2022," Montgomery said.The analyst said market participants are closely watching Trump's upcoming visit to China in May. "With President Trump still on track to visit China in mid-May, it would appear the market's anxiety over the prolonged conflict with Iran has subsided at least temporarily," Montgomery said in a daily note.

Research

Research Alert: CFRA Maintains Hold Opinion On Shares Of Kimberly-clark Corp

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target by $6 to $104, 14x our 2026 EPS estimate (from 16x), a discount to its 19x five-year average forward multiple, reflecting integration risks stemming from the acquisition of Kenvue Inc. (KVUE 17 ***). We lower our 2026 EPS estimate to $7.45 from $7.56 and keep 2027's at $6.31. Following Q1 results, we maintain our Hold rating, reflecting a balanced assessment of operational momentum, with adjusted EPS of $1.97 beating the $1.95 consensus estimate, against a conservative full-year outlook. Management maintained organic sales growth guidance despite the Q1 beat, disappointing investors that expected an upward revision. Operating margin contracted 60 bps as higher operational and raw material costs offset productivity gains. Additionally, the KVUE acquisition introduces integration risks, having received shareholder approval but still pending regulatory approval. At current levels, we see balanced risk/reward and would become more constructive if management raised guidance.

$KMB
Insider Trading

Kopin Insider Sold Shares Worth $461,597, According to a Recent SEC Filing

Paul Christopher Baker, Chief Operating Officer, on April 28, 2026, sold 116,860 shares in Kopin (KOPN) for $461,597. Following the Form 4 filing with the SEC, Baker has control over a total of 480,005 common shares of the company, with 480,005 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/771266/000149315226019551/xslF345X05/ownership.xmlPrice: $3.98, Change: $-0.02, Percent Change: -0.62%

$KOPN